Keeping equipment maintained, serviced and occasionally used can preserve readiness while avoiding the cost of running full surge capacity every day. The trade-off is the ongoing expense of service contracts, competency and quality control.
Laboratory Insight Report
Pandemic Readiness: Can Your Lab Sustain a Surge?
Laboratory leader perspectives on surge capacity, staffing endurance, supply resilience, LIS readiness and preparedness funding
Audience: Lab Managers / Supervisors / Directors
Countries: 2
Survey records: 10
-Hero findings
– Quick Read — Key Findings
👥
50.0%
📦
50.0%
🔄
62.5%
🛡️
50.0%
🧬
50.0%
⚠️
50.0%
If testing demand doubled in 48 hours, what would fail first?
The full report follows the weak points lab leaders identify across supply, specimen logistics, staffing endurance, LIS readiness and funding durability.
Preparedness is not a machine on standby. It is a system that can keep functioning under sustained demand.
CDC’s Laboratory Response Network is built around rapid testing, secure reporting, training and surge capability during public health emergencies. The MDForLives laboratory responses point to the same reality at an institutional level: readiness depends on more than molecular platforms. It also depends on reagents, specimen logistics, cross-trained staff, information systems and funding that survives the quiet years between crises.
Clinical context: CDC describes laboratory preparedness as an integrated capability that includes testing capacity, trained personnel, secure reporting, readiness exercises and the ability to support surge demand during public health emergencies.
MDForLives captured perspectives from Lab Managers / Supervisors / Directors across United States, Canada. The findings below focus on the operational and clinical patterns that stand out across the response data.
The first failure point is split between supply and specimen flow
When asked what would limit a 48-hour doubling of molecular throughput, respondents divide between reagent availability and specimen collection or transport.
What the pattern suggests: The bottleneck is not necessarily the analyzer. Capacity can be stranded upstream by collection logistics or downstream by supply and data flow.
Why it matters: Surge planning should map the complete diagnostic pathway, from collection to reporting, instead of measuring readiness by instrument count alone.
Half of pandemic-era molecular capacity found a permanent job
The strongest infrastructure signal is not mothballing. It is repurposing.
What the pattern suggests: Repurposing surge assets into respiratory panels, STI testing or other routine work can preserve staff familiarity and justify maintenance costs.
Why it matters: Infrastructure that earns its place in routine operations is easier to keep ready for the next surge.
The information layer looks stronger than the funding layer
Most respondents view their LIS reporting capability positively, even while dedicated preparedness funding appears fragile.
What the pattern suggests: Digital reporting may be one of the better-preserved pieces of readiness in this small sample.
Why it matters: A capable LIS reduces the administrative drag of a surge, but it cannot compensate for missing staff, reagents or maintenance budgets.
Supply resilience is still being bought as inventory
The most common shortage strategy is a 30 to 60 day surplus rather than platform diversification.
What the pattern suggests: Inventory is the most immediate hedge, but it has storage, expiry and financing costs.
Why it matters: Long-term resilience may require a portfolio approach that combines stock, vendor flexibility, alternative methods and validated backup workflows.
Cross-training is common, but workforce endurance is short
Most respondents report active cross-training, yet the same group signals that sustained surge staffing remains a vulnerability.
What the pattern suggests: Cross-training improves elasticity, but it does not create additional people. A surge can still exhaust a flexible team if baseline staffing is thin.
Why it matters: Preparedness plans need both skill mobility and staffing depth, including relief, retention and backup coverage.
Preparedness budgets are the most fragile layer
Only one respondent reports readiness as an explicitly funded priority.
What the pattern suggests: The quiet period after a crisis creates a predictable governance problem: preparedness looks expensive precisely when it is not being visibly used.
Why it matters: Readiness degrades gradually through expired stock, lapsed service contracts, staff turnover and lost competency long before the next emergency makes the gap obvious.
What respondents said when the answer choices disappeared
Supply chain resilience must be maintained between crises
Open comments return to reagent, PPE and vendor vulnerabilities, including the need for diversified supply and maintained stockpiles.
Laboratory capacity is broader than analyzer capacity
Respondents describe staffing, consumables, collection supplies and partnerships as part of the same readiness system.
Workforce endurance is a preparedness asset
Retention, cross-training and the physical and mental strain of sustained demand appear alongside technical capacity.
Preparedness should stay funded in non-crisis periods
The clearest qualitative warning is that resilience erodes when stockpiles, backup equipment and staffing investments are treated as temporary emergency costs.
What this tells us
Readiness is a system, not an analyzer
Reagents, specimen flow, reporting, staffing and backup capacity fail together when one layer is weak.
Cross-training creates elasticity
A workforce that can move across benches gives laboratories more room to absorb sudden volume.
Preparedness erodes between crises
Service contracts, inventory and workforce investment are easiest to cut precisely when they are least visible.
Pandemic Readiness: Can Your Lab Sustain a Surge?
These laboratory responses suggest that preparedness can remain technically capable while becoming operationally fragile. Molecular assets and LIS capability may stay in place even as funding and workforce endurance weaken. The next diagnostic surge will test whether hospitals preserved a complete readiness system, not simply the instruments purchased during the last crisis.
Endocrinology, Diabetes & Metabolism
7Oncology & Hematology
7Hospital Administration
6Dermatology
6Ophthalmology
6Gastroenterology & Hepatology
6Pharmacy
6Primary Care & Family Medicine
6Surgery & Procedural Care
5Diabetes, Weight & Metabolic Health
5Neurology
5Dentistry & Oral Health
5Nurses, NPs & Physician Assistants
5Pediatrics
5
Cardiology
4Laboratory & Diagnostics
4Radiology & Imaging
3Optometry & Optical Care
3Skin & Aesthetic Care
2Cancer Care
1Social Work & Patient Support
1Brain, Nerves & Mental Health
1
You have read the summary
The findings go deeper.
So can your participation.
Frequently asked questions
What does laboratory pandemic preparedness include?
Preparedness includes validated testing methods, trained staff, surge workflows, supply continuity, specimen logistics, biosafety, data reporting and the ability to scale operations during an emergency.
Why is surge capacity different from routine laboratory capacity?
Routine capacity is optimized for expected volume. Surge capacity must absorb sudden demand while maintaining turnaround time, quality and safety, often with disrupted supply chains and rapidly changing testing requirements.
Why is cross-training important in a diagnostic surge?
Cross-training gives laboratories more flexibility to redeploy staff when one discipline experiences a sudden volume spike. It works best when competencies are maintained and credentialing or scope requirements are addressed before an emergency.
What role does the LIS play in public health readiness?
The laboratory information system supports order intake, result management and electronic reporting. Automated interfaces can reduce manual entry and speed notification, but they still depend on reliable data standards and connections with public health systems.
Why do labs keep backup instruments in a “warm state”?
How can labs reduce reagent and consumable shortages?
Common strategies include safety stock, multiple suppliers or platforms, validated alternative methods, vendor agreements and coordinated regional partnerships. The right mix depends on storage, shelf life, regulatory requirements and local risk.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
